A detailed history of Envestnet Asset Management Inc transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Envestnet Asset Management Inc holds 13,366 shares of DVAX stock, worth $171,753. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,366
Previous 15,058 11.24%
Holding current value
$171,753
Previous $169,000 12.43%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$10.05 - $11.61 $17,004 - $19,644
-1,692 Reduced 11.24%
13,366 $148,000
Q2 2024

Aug 08, 2024

BUY
$10.73 - $12.58 $38,574 - $45,225
3,595 Added 31.36%
15,058 $169,000
Q1 2024

May 13, 2024

BUY
$11.7 - $14.98 $134,117 - $171,715
11,463 New
11,463 $142,000
Q4 2021

Feb 04, 2022

SELL
$13.17 - $20.94 $359,448 - $571,515
-27,293 Closed
0 $0
Q3 2021

Oct 07, 2021

BUY
$9.16 - $19.83 $250,003 - $541,220
27,293 New
27,293 $524,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.63B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.